Calimot, Madel L.

HRN: 22-02-71  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2024
CEFUROXIME 750MG (VIAL)
01/05/2024
01/12/2024
IV
750mg
Q8hr
Imminent Abortion
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamIntra-abdominal    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: